Resection, transplantation, either, or both? Other pieces of the puzzle
Pietro Majno, Gilles Mentha, Vincenzo Mazzaferro – 23 September 2005
Pietro Majno, Gilles Mentha, Vincenzo Mazzaferro – 23 September 2005
John Fung, Jorge Rakela – 23 September 2005
Shimon Kusne, Jerry Smilack – 23 September 2005
Neal R. Barshes, Timothy C. Lee, Rajesh Balkrishnan, Saul J. Karpen, Beth A. Carter, John A. Goss – 23 September 2005 – Biliary atresia is the most common indication for orthotopic liver transplantation (OLT) in the pediatric population. The outcomes of liver transplantation for biliary atresia, however, have not been formally examined on a national scale. The objective of this study was to identify pretransplant variables that predict patient survival after primary liver transplantation for biliary atresia.
Peter L. Abt, Ibrahim Abdullah, Kathleen Korenda, Adam Frank, Heather Peterman, G. Robert Stephenson, James F. Markmann, Abraham Shaked, Kim M. Olthoff – 23 September 2005 – Appendicitis among liver transplant recipients has not been described in the current literature. We report 8 recipients who experienced appendicitis three weeks to 181 months after liver transplantation (LT). Initial presenting findings differed from the nonimmunosuppressed population in that a majority of the patients did not have leukocytosis (>10,000 cells/mm3).
23 September 2005
Peter Stärkel, Michel Stoffel, Jan Lerut, Yves Horsmans – 23 September 2005 – Strategies using lamivudine and hepatitis B immunoglobulins (HBIg) for prevention of hepatitis B virus (HBV) reinfection after liver transplantation (LT) are expensive since life‐long treatment is needed.
Hubert Hetz, Michael Bauer, Daniel Lahner, Peter Faybik, Johannes Winning, Hendrik Jan Ankersmit, Andreas Bacher, Claus Georg Krenn – 23 September 2005 – Renal failure is an established risk factor for impaired patient outcome after orthotopic liver transplantation (OLT). As the endothelin pathway is known to be involved in the development of acute renal failure (ARF), we designed a study to clarify its role in ARF following OLT. Twenty consecutive patients with intact kidney function scheduled for their first OLT were prospectively studied.
Bjorn Brandsaeter, Erik Schrumpf, Oystein Bentdal, Kurt Brabrand, Hans Jorgen Smith, Andreas Abildgaard, Ole Petter Clausen, Kristian Bjoro – 23 September 2005 – Primary sclerosing cholangitis (PSC) is a well‐established indication for orthotopic liver transplantation (OLT), but post‐OLT bile duct strictures complicate the outcome for these patients. These strictures might represent recurrent PSC (rPSC).
Ariane Mallat, Christophe Hezode, Sophie Lotersztajn – 20 September 2005